{"created":"2023-05-15T14:36:14.294273+00:00","id":46648,"links":{},"metadata":{"_buckets":{"deposit":"1e7f53e3-2d2c-4977-af09-1f17bf3cff4d"},"_deposit":{"created_by":1,"id":"46648","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"46648"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00046648","sets":["1"]},"author_link":["465032","465036","465037","465038","465034","465033","465035"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2012-07","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"12","bibliographicPageEnd":"2","bibliographicPageStart":"1991","bibliographicVolumeNumber":"91","bibliographic_titles":[{"bibliographic_title":"Annals of Hematology"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The pharmacokinetic analysis of cyclosporine is essential for the management of refractory pure red cell aplasia","subitem_description_type":"Abstract"}]},"item_8_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1007/s00277-012-1519-x","subitem_relation_type_select":"DOI"}}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0939-5555","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Kato, Yuichi"}],"nameIdentifiers":[{"nameIdentifier":"465032","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Tajima, Katsushi"}],"nameIdentifiers":[{"nameIdentifier":"465033","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Suzuki, Ikuko"}],"nameIdentifiers":[{"nameIdentifier":"465034","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kohno, Kei"}],"nameIdentifiers":[{"nameIdentifier":"465035","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Hiroshima, Yuki"}],"nameIdentifiers":[{"nameIdentifier":"465036","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kato, Takeo"}],"nameIdentifiers":[{"nameIdentifier":"465037","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"田嶋 克史","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"465038","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"The pharmacokinetic analysis of cyclosporine is essential for the management of refractory pure red cell aplasia","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"The pharmacokinetic analysis of cyclosporine is essential for the management of refractory pure red cell aplasia"}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2013-12-02"},"publish_date":"2013-12-02","publish_status":"0","recid":"46648","relation_version_is_last":true,"title":["The pharmacokinetic analysis of cyclosporine is essential for the management of refractory pure red cell aplasia"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T23:49:16.387011+00:00"}